Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja
|
April 20, 2007
[Not Available]
Eija Korkeila, Sirkku Jyrkkiö, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
January 24, 2007
[Not Available]
Pia Osterlund, Raija Ristamäki, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
August 6, 2004
[Prognostic factors and improving treatment of cutaneous melanoma]
Pia Vihinen, Veli-Matti Kähäri, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
July 7, 2007
[Not Available]
Florence Schmitt, Eeva Salminen, Seppo Pyrhönen, et al.
Anticancer Research
|
July 31, 2012
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer
Eija Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
September 1, 2010
[Are immunological treatments beneficial for malignant melanoma of the skin?]
Pia Vihinen, Meri-Sisko Vuoristo, Micaela Hernberg, et al.
Anticancer Research
|
December 27, 2011
Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors
Eija A Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
World Journal of Clinical Oncology
|
August 13, 2014
Toremifene in the treatment of breast cancer
Mika Vj Mustonen, Seppo Pyrhönen, Pirkko-Liisa Kellokumpu-Lehtinen
Oncology Reports
|
October 25, 2008
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer
Riyad Bendardaf, Hanan Lamlum, Raija Ristamäki, et al.
Cancer Chemotherapy and Pharmacology
|
August 28, 2010
NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer
Johanna Hilli, Liisa Sailas, Sirkku Jyrkkiö, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Duodecim; Laaketieteellinen Aikakauskirja
|
April 20, 2007
[Not Available]
Eija Korkeila, Sirkku Jyrkkiö, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
January 24, 2007
[Not Available]
Pia Osterlund, Raija Ristamäki, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
August 6, 2004
[Prognostic factors and improving treatment of cutaneous melanoma]
Pia Vihinen, Veli-Matti Kähäri, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja
|
July 7, 2007
[Not Available]
Florence Schmitt, Eeva Salminen, Seppo Pyrhönen, et al.
Anticancer Research
|
July 31, 2012
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer
Eija Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
Duodecim; Laaketieteellinen Aikakauskirja
|
September 1, 2010
[Are immunological treatments beneficial for malignant melanoma of the skin?]
Pia Vihinen, Meri-Sisko Vuoristo, Micaela Hernberg, et al.
Anticancer Research
|
December 27, 2011
Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors
Eija A Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
World Journal of Clinical Oncology
|
August 13, 2014
Toremifene in the treatment of breast cancer
Mika Vj Mustonen, Seppo Pyrhönen, Pirkko-Liisa Kellokumpu-Lehtinen
Oncology Reports
|
October 25, 2008
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer
Riyad Bendardaf, Hanan Lamlum, Raija Ristamäki, et al.
Cancer Chemotherapy and Pharmacology
|
August 28, 2010
NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer
Johanna Hilli, Liisa Sailas, Sirkku Jyrkkiö, et al.
Page
of 7